| Field | Row 1 |
|---|---|
| adsh | 0001367644-25-000124 |
| cik | 1367644 |
| name | EMERGENT BIOSOLUTIONS INC. |
| sic | 2834 |
| countryba | US |
| stprba | MD |
| cityba | GAITHERSBURG |
| zipba | 20879 |
| bas1 | 300 PROFESSIONAL DR |
| bas2 | |
| baph | 240-631-3200 |
| countryma | US |
| stprma | MD |
| cityma | GAITHERSBURG |
| zipma | 20879 |
| mas1 | 300 PROFESSIONAL DR |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 141902018 |
| former | |
| changed | |
| afs | 2-ACC |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-07 17:46:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ebs-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001367644-25-000124 | 20250331 | Amortization Of Intangible Assets | 16300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 500000.0000 | USD | 1 | us-gaap/2024 | Business Segments= M C M Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20241231 | Cash And Cash Equivalents At Carrying Value | 99500000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -32700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Cost Of Goods And Services Sold | 61800000.0000 | USD | 1 | us-gaap/2024 | Business Segments= M C M Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Cost Of Goods And Services Sold | 24500000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Commercial Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Cost Of Goods And Services Sold | 73700000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Disposal Group Not Discontinued Operation Gain Loss On Disposal | -12200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Earnings Per Share Diluted | 1.1900 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Gain Loss On Disposition Of Assets1 | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Income Tax Expense Benefit | 24700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | -8400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Liabilities And Stockholders Equity | 1389700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Net Income Loss | 9000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001367644-25-000124 | 20241231 | Other Assets Noncurrent | 0.0000 | USD | 0 | us-gaap/2024 | Major Customers= Jansen Pharmaceuticals Inc; | ||
| 0001367644-25-000124 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Other Liabilities Noncurrent | 39100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Nonoperating Income Expense | 69700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Nonoperating Income Expense | 400000.0000 | USD | 1 | us-gaap/2024 | Disposal Group Classification= Disposal Group Disposed Of By Sale Not Discontinued Operations; Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations= Baltimore Camden Facility; | ||
| 0001367644-25-000124 | 20241231 | Preferred Stock Shares Authorized | 15000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Research And Development Expense | 15100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 118500000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Commercial Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 900000.0000 | USD | 1 | us-gaap/2024 | Disposal Group Classification= Disposal Group Disposed Of By Sale Not Discontinued Operations; Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations= R S D L; Product Or Service= Product And Service; | ||
| 0001367644-25-000124 | 20231231 | Stockholders Equity | 649300000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Stockholders Equity | -144400000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001367644-25-000124 | 20240331 | Stock Issued During Period Value Share Based Compensation | 5400000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001367644-25-000124 | 20250331 | Treasury Stock Common Shares | 5600000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Treasury Stock Common Value | 227700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Accounts Payable Current | 58100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Amortization Of Financing Costs | 6900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Assets | 1389700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Assets Current | 706800000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 3300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Common Stock Shares Issued | 59900000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Deferred Income Tax Liabilities Net | 60400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Income Tax Expense Benefit | 3100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Accounts Payable | -5400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Inventories | 4500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Intangible Assets Net Excluding Goodwill | 501500000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Interest Paid Net | 16700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Liabilities Current | 111900000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Net Cash Provided By Used In Operating Activities | -11200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Net Income Loss | 68000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001367644-25-000124 | 20250331 | Nonoperating Income Expense | 42800000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Payments To Acquire Notes Receivable | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Payments To Acquire Notes Receivable | 5000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Proceeds From Sale Of Property Plant And Equipment | 38100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Research And Development Expense | 15100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 300400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 19100000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; Product Or Service= All Other Revenue; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 8000000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Contracts And Grants; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 143400000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 78800000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; | ||
| 0001367644-25-000124 | 20240331 | Share Based Compensation | 5900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Stockholders Equity | -227700000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20250331 | Stockholders Equity | 100000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20240331 | Treasury Stock Common Shares | 5600000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20241231 | Treasury Stock Common Shares | 5600000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20250331 | Treasury Stock Common Value | 227700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Accounts Payable Current | 60900000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -6100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Additional Paid In Capital | 928000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Amortization Of Financing Costs | 2300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Amortization Of Intangible Assets | 16200000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 0.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Common Stock Shares Issued | 60100000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Common Stock Value | 100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Comprehensive Income Net Of Tax | 9200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 12100000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 92700000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Accrued Liabilities | 1100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Inventories | 2200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Long Term Incentive Plan Accrual | 1200000.0000 | USD | 1 | 0001367644-25-000124 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 6000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Inventory Net | 314000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Net Income Loss | 9000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Nonoperating Income Expense | 69700000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Repayments Of Medium Term Notes | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 273900000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 7400000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; Product Or Service= All Other Revenue; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 45300000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Commercial Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 45200000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; Product Or Service= Commercial Product; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 66600000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; Product Or Service= Medical Countermeasures M C M Product; | ||
| 0001367644-25-000124 | 20231231 | Stockholders Equity | 904400000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001367644-25-000124 | 20240331 | Stockholders Equity | -12800000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001367644-25-000124 | 20241231 | Stockholders Equity | 482800000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Stockholders Equity | -212400000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001367644-25-000124 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 200000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2800000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2800000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001367644-25-000124 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 52200000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 57300000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Amortization Of Intangible Assets | 16200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Assets Of Disposal Group Including Discontinued Operation Current | 6100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 1500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 79000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 105600000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20231231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Common Stock Shares Issued | 58000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20250331 | Common Stock Shares Issued | 60100000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20241231 | Common Stock Shares Outstanding | 54300000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Common Stock Value | 100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Comprehensive Income Net Of Tax | 67100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Deferred Income Tax Liabilities Net | 41700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Earnings Per Share Basic | 1.2500 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Earnings Per Share Diluted | 0.1700 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 12100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Long Term Incentive Plan Accrual | 800000.0000 | USD | 1 | 0001367644-25-000124 | |||
| 0001367644-25-000124 | 20240331 | Interest Paid Net | 21500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Liabilities | 906900000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Nonoperating Income Expense | -27700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Operating Costs And Expenses | 172300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240630 | Other Assets Noncurrent | 158700000.0000 | USD | 0 | us-gaap/2024 | Major Customers= Jansen Pharmaceuticals Inc; | ||
| 0001367644-25-000124 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Payments To Acquire Property Plant And Equipment | 3600000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Proceeds From Sale Of Property Plant And Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Property Plant And Equipment Net | 221000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Restricted Cash | 500000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Restricted Cash Current | 3700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 155400000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Medical Countermeasures M C M Product; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 222200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 156600000.0000 | USD | 1 | us-gaap/2024 | Business Segments= M C M Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 12100000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; Product Or Service= All Other Revenue; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 100000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; Product Or Service= Commercial Product; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 13100000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Contracts And Grants; | ||
| 0001367644-25-000124 | 20240331 | Stock Issued During Period Value Share Based Compensation | 5400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Accounts Receivable Net Current | 154500000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Additional Paid In Capital | 930800000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 47200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20231231 | Common Stock Shares Issued | 57800000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20240331 | Cost Of Goods And Services Sold | 52100000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Commercial Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Cost Of Goods And Services Sold | 113900000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Deferred Income Taxes And Tax Credits | -12200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Gains Losses On Extinguishment Of Debt | 300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Accounts Payable | -2400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Accounts Receivable | 73300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Accrued Liabilities | -7200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Inventory Net | 311700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Liabilities Of Disposal Group Including Discontinued Operation Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Liabilities Of Disposal Group Including Discontinued Operation Current | 4800000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Net Cash Provided By Used In Investing Activities | 59500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Other Assets Noncurrent | 18900000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Liabilities Current | 11100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Payments For Proceeds From Contingent Consideration Liability Asset Investing Activities | -30000000.0000 | USD | 1 | 0001367644-25-000124 | |||
| 0001367644-25-000124 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Proceeds From Long Term Lines Of Credit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Research And Development Expense | 15100000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Retained Earnings Accumulated Deficit | -144400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 121800000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; | ||
| 0001367644-25-000124 | 20240630 | Revenue From Contract With Customer Excluding Assessed Tax | 50000000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Jansen Pharmaceuticals Inc; Product Or Service= Product And Service; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 20300000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Material Reconciling Items; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 8200000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; Product Or Service= All Other Revenue; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 45300000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Commercial Product; | ||
| 0001367644-25-000124 | 20250331 | Selling General And Administrative Expense | 52400000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20231231 | Stockholders Equity | -227700000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20241231 | Stockholders Equity | -227700000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20231231 | Treasury Stock Common Shares | 5600000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20250331 | Accounts Receivable Net Current | 203700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -5200000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Amortization Of Intangible Assets | 16300000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 500000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Cash And Cash Equivalents At Carrying Value | 78500000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Cash And Cash Equivalents At Carrying Value | 149100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 111700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 152800000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240630 | Cost Of Goods And Services Sold | 50000000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Jansen Pharmaceuticals Inc; | ||
| 0001367644-25-000124 | 20250331 | Cost Of Goods And Services Sold | 49200000.0000 | USD | 1 | us-gaap/2024 | Business Segments= M C M Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Deferred Income Taxes And Tax Credits | 18600000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Fair Value Adjustment Of Warrants | -9500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Gain Loss On Disposition Of Assets1 | -300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Income Taxes Paid | 12400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Contract With Customer Liability | -19700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Interest Expense Nonoperating | 24300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Interest Expense Nonoperating | 24300000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Interest Expense Nonoperating | 14700000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Liabilities And Stockholders Equity | 1426100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Liabilities Current | 162400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Long Term Debt Noncurrent | 663700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Net Cash Provided By Used In Investing Activities | -10800000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Net Cash Provided By Used In Operating Activities | -62600000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Operating Costs And Expenses | 260600000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Operating Income Loss | 39800000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Other Nonoperating Income Expense | -3400000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Repayments Of Lines Of Credit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Restricted Cash | 3700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Restricted Cash Current | 6100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Retained Earnings Accumulated Deficit | -212400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 155400000.0000 | USD | 1 | us-gaap/2024 | Business Segments= M C M Products Segment; Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 178600000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 300000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; Product Or Service= Commercial Product; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 26500000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= All Other Revenue; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 292400000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product And Service; | ||
| 0001367644-25-000124 | 20240331 | Selling General And Administrative Expense | 84700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Share Based Compensation | 1500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Stockholders Equity | -5500000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001367644-25-000124 | 20240331 | Stockholders Equity | 909800000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001367644-25-000124 | 20241231 | Stockholders Equity | -5200000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001367644-25-000124 | 20241231 | Stockholders Equity | 928000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001367644-25-000124 | 20250331 | Stockholders Equity | 552700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 200000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20250331 | Assets | 1426100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Assets Current | 598700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Assets Of Disposal Group Including Discontinued Operation Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Cost Of Goods And Services Sold | 144600000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Disposal Group Not Discontinued Operation Gain Loss On Disposal | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Employee Related Liabilities Current | 24700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Fair Value Adjustment Of Warrants | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 92700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Income Taxes Paid | 14500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Accounts Receivable | 50000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Employee Related Liabilities | -33300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Employee Related Liabilities | -32200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | 16100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -9500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Long Term Debt Noncurrent | 665700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Net Cash Provided By Used In Financing Activities | 40700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Net Cash Provided By Used In Financing Activities | -400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Net Income Loss | 68000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 200000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001367644-25-000124 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -900000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001367644-25-000124 | 20240331 | Other Noncash Income Expense | 3100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Noncash Income Expense | 11300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Other Nonoperating Income Expense | -3400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Payments For Proceeds From Contingent Consideration Liability Asset Investing Activities | 0.0000 | USD | 1 | 0001367644-25-000124 | |||
| 0001367644-25-000124 | 20250331 | Preferred Stock Shares Authorized | 15000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Proceeds From Long Term Lines Of Credit | 50000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Repayments Of Lines Of Credit | 5000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 41300000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; Product Or Service= Medical Countermeasures M C M Product; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 118500000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Commercial Product; | ||
| 0001367644-25-000124 | 20231231 | Stockholders Equity | -5700000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001367644-25-000124 | 20231231 | Stockholders Equity | -21800000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001367644-25-000124 | 20241231 | Treasury Stock Common Shares | 5600000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Interest Expense Nonoperating | 14700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Liabilities | 873400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Operating Income Loss | 49900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Intangible Assets Net Excluding Goodwill | 485200000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Assets Noncurrent | 13100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Accrued Liabilities Current | 17700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Accrued Liabilities Current | 13200000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Common Stock Shares Issued | 59900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20250331 | Common Stock Shares Outstanding | 54500000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Cost Of Goods And Services Sold | 88500000.0000 | USD | 1 | us-gaap/2024 | (1) Exclusive of intangible asset amortization | ||
| 0001367644-25-000124 | 20240331 | Depreciation Depletion And Amortization | 27900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Depreciation Depletion And Amortization | 25400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Earnings Per Share Basic | 0.1700 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Employee Related Liabilities Current | 56100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Gains Losses On Extinguishment Of Debt | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Increase Decrease In Contract With Customer Liability | -300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Other Liabilities Current | 27700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Other Liabilities Noncurrent | 35400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Payments To Acquire Property Plant And Equipment | 10800000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Prepaid Expense And Other Assets Current | 26900000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Prepaid Expense And Other Assets Current | 30200000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20241231 | Property Plant And Equipment Net | 270600000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Repayments Of Medium Term Notes | 3900000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Research And Development Expense | 15100000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 26500000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Material Reconciling Items; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 118200000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; Product Or Service= Commercial Product; | ||
| 0001367644-25-000124 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 114100000.0000 | USD | 1 | us-gaap/2024 | Major Customers= United States Government; Product Or Service= Medical Countermeasures M C M Product; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 201900000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 90000000.0000 | USD | 1 | us-gaap/2024 | Major Customers= Non United States Government; Product Or Service= Medical Countermeasures M C M Product; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 20300000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= All Other Revenue; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 156600000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Medical Countermeasures M C M Product; | ||
| 0001367644-25-000124 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 209100000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product And Service; | ||
| 0001367644-25-000124 | 20240331 | Selling General And Administrative Expense | 84700000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001367644-25-000124 | 20250331 | Selling General And Administrative Expense | 52400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20231231 | Stockholders Equity | 100000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20240331 | Stockholders Equity | 663900000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20240331 | Stockholders Equity | 100000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20241231 | Stockholders Equity | 100000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001367644-25-000124 | 20250331 | Stockholders Equity | -6100000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001367644-25-000124 | 20250331 | Stockholders Equity | 930800000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001367644-25-000124 | 20250331 | Stockholders Equity | -227700000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20250331 | Treasury Stock Common Shares | 5600000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001367644-25-000124 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 52200000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001367644-25-000124 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 54400000.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Liabilities Of Disposal Group Including Discontinued Operation Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Disposal Group, Including Discontinued Operation, Liabilities, Current | Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Gain Loss On Disposition Of Assets1 | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Assets | Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Restricted Cash Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Disposal Group Not Discontinued Operation Gain Loss On Disposal | us-gaap/2024 | 0 | 0 | monetary | D | C | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Income Taxes Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid | Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Increase Decrease In Employee Related Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Other Noncash Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Assets Of Disposal Group Including Discontinued Operation Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Disposal Group, Including Discontinued Operation, Assets, Current | Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer. |
| Repayments Of Medium Term Notes | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Medium-Term Note | The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years. |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | us-gaap/2024 | 0 | 0 | monetary | D | D | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. |
| Employee Related Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Proceeds From Long Term Lines Of Credit | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Long-Term Lines of Credit | The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer. |
| Restricted Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash | Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Amortization Of Financing Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs | Amount of amortization expense attributable to debt issuance costs. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Deferred Income Taxes And Tax Credits | us-gaap/2024 | 0 | 0 | monetary | D | D | Deferred Income Taxes and Tax Credits | Amount of deferred income tax expense (benefit) and income tax credits. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Gains Losses On Extinguishment Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Extinguishment of Debt | Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. |
| Deferred Income Tax Liabilities Net | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Income Tax Liabilities, Net | Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting. |
| Fair Value Adjustment Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Operating Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Payments To Acquire Notes Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Notes Receivable | The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Repayments Of Lines Of Credit | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Lines of Credit | Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. |
| Treasury Stock Common Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Common, Value | Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Increase Decrease In Long Term Incentive Plan Accrual | 0001367644-25-000124 | 1 | 0 | monetary | D | D | Increase (Decrease) in Long-Term Incentive Plan Accrual | Increase (Decrease) in Long-Term Incentive Plan Accrual |
| Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Payments For Proceeds From Contingent Consideration Liability Asset Investing Activities | 0001367644-25-000124 | 1 | 0 | monetary | D | C | Payments For (Proceeds From) Contingent Consideration Liability (Asset), Investing Activities | Payments For (Proceeds From) Contingent Consideration Liability (Asset), Investing Activities |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001367644-25-000124 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001367644-25-000124 | 2 | 4 | BS | 0 | H | Restricted Cash Current | us-gaap/2024 | Restricted cash | 0 |
| 0001367644-25-000124 | 2 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001367644-25-000124 | 2 | 6 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories, net | 0 |
| 0001367644-25-000124 | 2 | 7 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001367644-25-000124 | 2 | 8 | BS | 0 | H | Assets Of Disposal Group Including Discontinued Operation Current | us-gaap/2024 | Assets held for sale | 0 |
| 0001367644-25-000124 | 2 | 9 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001367644-25-000124 | 2 | 10 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property, plant and equipment, net | 0 |
| 0001367644-25-000124 | 2 | 11 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangible assets, net | 0 |
| 0001367644-25-000124 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001367644-25-000124 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001367644-25-000124 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001367644-25-000124 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001367644-25-000124 | 2 | 18 | BS | 0 | H | Employee Related Liabilities Current | us-gaap/2024 | Accrued compensation | 0 |
| 0001367644-25-000124 | 2 | 19 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
| 0001367644-25-000124 | 2 | 20 | BS | 0 | H | Liabilities Of Disposal Group Including Discontinued Operation Current | us-gaap/2024 | Liabilities held for sale | 0 |
| 0001367644-25-000124 | 2 | 21 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001367644-25-000124 | 2 | 22 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Debt | 0 |
| 0001367644-25-000124 | 2 | 23 | BS | 0 | H | Deferred Income Tax Liabilities Net | us-gaap/2024 | Deferred tax liability | 0 |
| 0001367644-25-000124 | 2 | 24 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other liabilities | 0 |
| 0001367644-25-000124 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001367644-25-000124 | 2 | 27 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value per share; 15.0 shares authorized, no shares issued or outstanding | 0 |
| 0001367644-25-000124 | 2 | 28 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value per share; 200.0 shares authorized, 60.1 and 59.9 shares issued; 54.5 and 54.3 shares outstanding, respectively | 0 |
| 0001367644-25-000124 | 2 | 29 | BS | 0 | H | Treasury Stock Common Value | us-gaap/2024 | Treasury stock, at cost, 5.6 and 5.6 common shares, respectively | 1 |
| 0001367644-25-000124 | 2 | 30 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001367644-25-000124 | 2 | 31 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss, net | 0 |
| 0001367644-25-000124 | 2 | 32 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001367644-25-000124 | 2 | 33 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001367644-25-000124 | 2 | 34 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0001367644-25-000124 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001367644-25-000124 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized (in shares) | 0 |
| 0001367644-25-000124 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued (in shares) | 0 |
| 0001367644-25-000124 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001367644-25-000124 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001367644-25-000124 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
| 0001367644-25-000124 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued (in shares) | 0 |
| 0001367644-25-000124 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding (in shares) | 0 |
| 0001367644-25-000124 | 3 | 11 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury stock (in shares) | 0 |
| 0001367644-25-000124 | 4 | 8 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Total revenues | 0 |
| 0001367644-25-000124 | 4 | 10 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of goods and services sold | 0 |
| 0001367644-25-000124 | 4 | 11 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001367644-25-000124 | 4 | 12 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0001367644-25-000124 | 4 | 13 | IS | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangible assets | 0 |
| 0001367644-25-000124 | 4 | 14 | IS | 0 | H | Operating Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001367644-25-000124 | 4 | 15 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Income from operations | 0 |
| 0001367644-25-000124 | 4 | 17 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0001367644-25-000124 | 4 | 18 | IS | 0 | H | Disposal Group Not Discontinued Operation Gain Loss On Disposal | us-gaap/2024 | Loss on assets held for sale | 0 |
| 0001367644-25-000124 | 4 | 19 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other, net | 0 |
| 0001367644-25-000124 | 4 | 20 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income (expense), net | 0 |
| 0001367644-25-000124 | 4 | 21 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income before income taxes | 0 |
| 0001367644-25-000124 | 4 | 22 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax provision | 0 |
| 0001367644-25-000124 | 4 | 23 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001367644-25-000124 | 4 | 25 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic (in dollars per share) | 0 |
| 0001367644-25-000124 | 4 | 26 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted (in dollars per share) | 0 |
| 0001367644-25-000124 | 4 | 28 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic (in shares) | 0 |
| 0001367644-25-000124 | 4 | 29 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted (in shares) | 0 |
| 0001367644-25-000124 | 5 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001367644-25-000124 | 5 | 3 | CI | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Foreign currency translation adjustments, net | 0 |
| 0001367644-25-000124 | 5 | 4 | CI | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Total other comprehensive income (loss), net of tax | 0 |
| 0001367644-25-000124 | 5 | 5 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive income, net of tax | 0 |
| 0001367644-25-000124 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001367644-25-000124 | 6 | 4 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation expense | 0 |
| 0001367644-25-000124 | 6 | 5 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001367644-25-000124 | 6 | 6 | CF | 0 | H | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | us-gaap/2024 | Change in fair value of contingent obligations, net | 0 |
| 0001367644-25-000124 | 6 | 7 | CF | 0 | H | Amortization Of Financing Costs | us-gaap/2024 | Amortization of deferred financing costs | 0 |
| 0001367644-25-000124 | 6 | 8 | CF | 0 | H | Deferred Income Taxes And Tax Credits | us-gaap/2024 | Deferred income taxes | 0 |
| 0001367644-25-000124 | 6 | 9 | CF | 0 | H | Disposal Group Not Discontinued Operation Gain Loss On Disposal | us-gaap/2024 | Noncash loss on assets held for sale | 1 |
| 0001367644-25-000124 | 6 | 10 | CF | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Change in fair value of warrant liability | 0 |
| 0001367644-25-000124 | 6 | 11 | CF | 0 | H | Gain Loss On Disposition Of Assets1 | us-gaap/2024 | Loss on disposal of assets | 1 |
| 0001367644-25-000124 | 6 | 12 | CF | 0 | H | Other Noncash Income Expense | us-gaap/2024 | Other | 1 |
| 0001367644-25-000124 | 6 | 14 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001367644-25-000124 | 6 | 15 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
| 0001367644-25-000124 | 6 | 16 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0001367644-25-000124 | 6 | 17 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001367644-25-000124 | 6 | 18 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0001367644-25-000124 | 6 | 19 | CF | 0 | H | Increase Decrease In Long Term Incentive Plan Accrual | 0001367644-25-000124 | Long-term incentive plan accrual | 0 |
| 0001367644-25-000124 | 6 | 20 | CF | 0 | H | Increase Decrease In Employee Related Liabilities | us-gaap/2024 | Accrued compensation | 0 |
| 0001367644-25-000124 | 6 | 21 | CF | 0 | H | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | us-gaap/2024 | Income taxes receivable and payable, net | 0 |
| 0001367644-25-000124 | 6 | 22 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2024 | Contract liabilities | 0 |
| 0001367644-25-000124 | 6 | 23 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001367644-25-000124 | 6 | 25 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property, plant and equipment | 1 |
| 0001367644-25-000124 | 6 | 26 | CF | 0 | H | Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | Proceeds from sale of property, plant and equipment | 0 |
| 0001367644-25-000124 | 6 | 27 | CF | 0 | H | Payments For Proceeds From Contingent Consideration Liability Asset Investing Activities | 0001367644-25-000124 | Milestone payments from prior asset divestiture | 1 |
| 0001367644-25-000124 | 6 | 28 | CF | 0 | H | Payments To Acquire Notes Receivable | us-gaap/2024 | Purchase of convertible note receivable | 1 |
| 0001367644-25-000124 | 6 | 29 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
| 0001367644-25-000124 | 6 | 31 | CF | 0 | H | Repayments Of Medium Term Notes | us-gaap/2024 | Principal payments on term loan facility | 1 |
| 0001367644-25-000124 | 6 | 32 | CF | 0 | H | Proceeds From Long Term Lines Of Credit | us-gaap/2024 | Proceeds from revolving credit facility | 0 |
| 0001367644-25-000124 | 6 | 33 | CF | 0 | H | Repayments Of Lines Of Credit | us-gaap/2024 | Principal payments on revolving credit facility | 1 |
| 0001367644-25-000124 | 6 | 34 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | Proceeds from share-based compensation activity | 0 |
| 0001367644-25-000124 | 6 | 35 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Taxes paid for share-based compensation activity | 1 |
| 0001367644-25-000124 | 6 | 36 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities: | 0 |
| 0001367644-25-000124 | 6 | 37 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 |
| 0001367644-25-000124 | 6 | 38 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change in cash, cash equivalents and restricted cash | 0 |
| 0001367644-25-000124 | 6 | 39 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash, beginning of period | 0 |
| 0001367644-25-000124 | 6 | 40 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash, end of period | 0 |
| 0001367644-25-000124 | 6 | 42 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001367644-25-000124 | 6 | 43 | CF | 0 | H | Income Taxes Paid | us-gaap/2024 | Cash paid for income taxes, net of refunds | 0 |
| 0001367644-25-000124 | 6 | 45 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Purchases of property, plant and equipment unpaid at period end | 0 |
| 0001367644-25-000124 | 6 | 46 | CF | 0 | H | Gains Losses On Extinguishment Of Debt | us-gaap/2024 | Gain on extinguishment of debt | 0 |
| 0001367644-25-000124 | 6 | 48 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001367644-25-000124 | 6 | 49 | CF | 0 | H | Restricted Cash | us-gaap/2024 | Restricted cash | 0 |
| 0001367644-25-000124 | 6 | 50 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Total | 0 |
| 0001367644-25-000124 | 7 | 11 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001367644-25-000124 | 7 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0001367644-25-000124 | 7 | 13 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Beginning balance (in shares) | 1 |
| 0001367644-25-000124 | 7 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
| 0001367644-25-000124 | 7 | 15 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Share-based compensation activity (in shares) | 0 |
| 0001367644-25-000124 | 7 | 16 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Share-based compensation activity | 0 |
| 0001367644-25-000124 | 7 | 17 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Other comprehensive income (loss), net of tax | 0 |
| 0001367644-25-000124 | 7 | 18 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001367644-25-000124 | 7 | 19 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0001367644-25-000124 | 7 | 20 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Ending balance (in shares) | 1 |
| 0001367644-25-000124 | 8 | 1 | EQ | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |